BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33039709)

  • 21.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the Progression of Fusobacterium nucleatum-induced Apical Periodontitis on the Gut Microbiota.
    Haraga H; Sato T; Watanabe K; Hamada N; Tani-Ishii N
    J Endod; 2022 Aug; 48(8):1038-1045. PubMed ID: 35545147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a bacteriocin-producing
    Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
    Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of
    Borowsky J; Haruki K; Lau MC; Dias Costa A; Väyrynen JP; Ugai T; Arima K; da Silva A; Felt KD; Zhao M; Gurjao C; Twombly TS; Fujiyoshi K; Väyrynen SA; Hamada T; Mima K; Bullman S; Harrison TA; Phipps AI; Peters U; Ng K; Meyerhardt JA; Song M; Giovannucci EL; Wu K; Zhang X; Freeman GJ; Huttenhower C; Garrett WS; Chan AT; Leggett BA; Whitehall VLJ; Walker N; Brown I; Bettington M; Nishihara R; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    Clin Cancer Res; 2021 May; 27(10):2816-2826. PubMed ID: 33632927
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Wang M; Wang Z; Lessing DJ; Guo M; Chu W
    Microbiol Spectr; 2023 Dec; 11(6):e0229223. PubMed ID: 37889013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Rubinstein MR; Baik JE; Lagana SM; Han RP; Raab WJ; Sahoo D; Dalerba P; Wang TC; Han YW
    EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30833345
    [No Abstract]   [Full Text] [Related]  

  • 30. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
    Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
    J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness.
    Hong XL; Yu TC; Huang XW; Wang JL; Sun TT; Yan TT; Zhou CB; Chen HM; Su WY; Du W; Xiong H
    Br J Cancer; 2023 Jan; 128(2):363-374. PubMed ID: 36396820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Performance of Intestinal
    Peng BJ; Cao CY; Li W; Zhou YJ; Zhang Y; Nie YQ; Cao YW; Li YY
    Chin Med J (Engl); 2018 Jun; 131(11):1349-1356. PubMed ID: 29786050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis.
    Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X
    Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism.
    Lin S; Zhang X; Zhu X; Jiao J; Wu Y; Li Y; Zhao L
    J Periodontol; 2023 Mar; 94(3):405-418. PubMed ID: 36088655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
    Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
    Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral-gut microbial transmission promotes diabetic coronary heart disease.
    Li Y; Liu Y; Cui J; Zhu M; Wang W; Chen K; Huang L; Liu Y
    Cardiovasc Diabetol; 2024 Apr; 23(1):123. PubMed ID: 38581039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.
    Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA
    mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.